Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods
暂无分享,去创建一个
E Biganzoli | P Boracchi | F Ambrogi | AR Green | JM Garibaldi | D Soria | G Ball | PJG Lisboa | TA Etchells | RD Macmillan | RW Blamey | DG Powe | EA Rakha | IO Ellis
[1] G. Ball,et al. High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.
[2] S. Boulton. Cellular functions of the BRCA tumour-suppressor proteins. , 2006, Biochemical Society transactions.
[3] Thomas Helleday,et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.
[4] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.